A scientific study on Mritasanjeevana Rasa - an Ayurvedic medicine

Phase 2

Not yet recruiting

• Conditions: Rheumatoid arthritis with rheumatoid factor, unspecified,

• Registration Number: CTRI/2020/04/024876
• Lead Sponsor: National Institute of Ayurveda Jaipur

Brief Summary

Amavata which resembles with Rheumatoid arthritis is a disease with high prevalence in middle age group, especially females. Rasashastra, pharmaceutical branch of Ayurveda provides potent and fast-acting medications against Amavata. This study aims at evaluating clinical efficacy of Mritasanjeevana Rasa (MRC) and its modified formulation (MRM) on Amavata (Rheumatoid Arthritis). AIM To comparatively evaluate clinical effect of MRC and MRM on Amavata (Rheumatoid Arthritis) OBJECTIVES 1. To review literature on Mritasanjeevana Rasa. 2. To prepare classical formulation of Mritasanjeevana Rasa (MRC) and modified formulation of Mritasanjeevana Rasa (MRM) 3. To analyze the prepared samples of both formulations 4. To assess changes in signs and symptoms of Amavata 5. To assess changes in investigatory parameters Null Hypothesis (H0) – There is no significant efficacy of MRC and MRM on Amavata. Alternative Hypothesis (H1) – MRC and MRM are significantly effective on Amavata.

Detailed Description

Not available

Study Timeline

• Study Start: 2020-01-10
• Last Update Posted: 2021-01-21

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

• Patients present with classical signs & symptoms of Amavata.
• Patients willing to give informed consent to participate for 28 days.

Exclusion Criteria

• Patients present with systemic diseases like Diabetes mellitus, Cardiac Disease, Hypertension, etc.
• Patients on prolonged ( > 6 weeks) medication with corticosteroids, etc.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Alteration in Disease Activity Score (DAS28)	28 days

Secondary Outcome Measures

Name	Time	Method
Changes in signs and symptoms	28 days

Trial Locations

Locations (1)

Arogyashala, National Institute of Ayurved; 🇮🇳 Jaipur, RAJASTHAN, India

Arogyashala, National Institute of Ayurved

🇮🇳Jaipur, RAJASTHAN, India

DrVarad Charkha

Principal investigator

9404883311

varadcharkha113@gmail.com